Recent Quotes

My Watchlist

Indicators

Vivos Therapeutics Inc (NQ: VVOS )

2.840 +0.130 (+4.80%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	151,958
Open	2.740
Bid (Size)	2.790 (1)
Ask (Size)	2.890 (2)
Prev. Close	2.710
Today's Range	2.680 - 2.890
52wk Range	1.910 - 48.79
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices

October 08, 2024

Via Investor Brand Network

Crude Oil Gains Over 1%; Mobileye Global Shares Jump

September 19, 2024

Via Benzinga

Performance

YTD	-75.93%	-75.93%
1 Month	+17.84%	+17.84%
3 Month	+38.66%	+38.66%
6 Month	+29.68%	+29.68%
1 Year	-13.68%	-13.68%

More News

Dow Jumps Over 500 Points; FactSet Research Posts Upbeat Earnings

September 19, 2024

Via Benzinga

Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today

September 19, 2024

Via Benzinga

TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces $4.3M Registered Direct Offering

September 19, 2024

Via Investor Brand Network

Nasdaq Surges 400 Points; US Jobless Claims Fall To 219,000

September 19, 2024

Via Benzinga

Nvidia, T-Mobile US, Vivos Therapeutics, SoFi Technologies, Tesla: Why These 5 Stocks Are On Investors' Radars Today

September 18, 2024

Via Benzinga

Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children

September 18, 2024

Via Benzinga

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Awarded First-Ever FDA Clearance for Pediatric Treatment of Sleep Apnea, Snoring

September 18, 2024

Via Investor Brand Network

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Report on Q2 2024 Financial Results, Operational Update

August 15, 2024

Via Investor Brand Network

VVOS Stock Earnings: Vivos Therapeutics Beats EPS, Beats Revenue for Q2 2024

August 14, 2024

Via InvestorPlace

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Plans Release of Q2 2024 Financial Results, Conference Call

August 14, 2024

Via Investor Brand Network

TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports Results of Seven-Month Provider-Based Marketing and Distribution Model Pilot

June 27, 2024

Via Investor Brand Network

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Strategic Alliance, Private Equity Investment

June 12, 2024

Via Investor Brand Network

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q1 2024 Financial Report, Operational Update

May 15, 2024

Via Investor Brand Network

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

May 15, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

May 15, 2024

Via InvestorPlace

VVOS Stock Earnings: Vivos Therapeutics Reported Results for Q1 2024

May 14, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session

May 14, 2024

Via Benzinga

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Schedules Release of Q1 2024 Results, Conference Call

May 14, 2024

Via Investor Brand Network

TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Discusses Medicare Reimbursement Approval for CARE Oral Medical Devices in Proactive Interview

April 10, 2024

Via Investor Brand Network

TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Achieves Milestone with CARE Oral Medical Devices Gaining Approval for Medicare Reimbursement

April 09, 2024

Via Investor Brand Network

What's Going On With Vivos Therapeutics Stock?

April 09, 2024

Via Benzinga

Why Is Laser Photonics (LASE) Stock Up 130% Today?

April 09, 2024

Via InvestorPlace

Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?

April 09, 2024

Via InvestorPlace

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.